The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6

Blood

Volumn 123, Issue 14, 2014, Pages 2261-2268

  Mayeur, Claire ^a   Lohmeyer, Lisa K ^a,d   Leyton, Patricio ^a   Kao, Sonya M ^a   Pappas, Alexandra E ^a   Kolodziej, Starsha A ^a   Spagnolli, Ester ^a   Yu, Binglan ^a   Galdos, Rita L ^a   Yu, Paul B ^a,b   Peterson, Randall T ^a   Bloch, Donald B ^a   Bloch, Kenneth D ^a   Steinbicker, Andrea U ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXY 1 METHYLTETRALIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; HEPCIDIN; IRON; LIVER PROTEIN; MESSENGER RNA; RECOMBINANT INTERLEUKIN 6; STAT3 PROTEIN; TRANSFERRIN; BMPR1A PROTEIN, MOUSE; INTERLEUKIN 6;

ADENOVIRUS; ANEMIA; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE DELETION; HOMEOSTASIS; HUMAN; HUMAN CELL; IRON BLOOD LEVEL; IRON METABOLISM; LIVER CELL; LONG TERM EXPOSURE; LOXP SITE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; ANIMAL; C57BL MOUSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; LIVER; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPCIDINS; HUMANS; INTERLEUKIN-6; IRON; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 84902105343     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-480095     Document Type: Article

References (37)

1. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-1023.
2. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA. 2002;99(7):4596-4601. (Pubitemid 34286030)
3. Sasu BJ, Cooke KS, Arvedson TL, et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood. 2010;115(17):3616-3624.
4. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110(7):1037-1044.
5. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276(11):7811-7819.
6. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-2093. (Pubitemid 40007660)
7. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101(7):2461-2463. (Pubitemid 36857598)
8. Besson-Fournier C, Latour C, Kautz L, et al. Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood. 2012;120(2):431-439.
9. Fleming MD. The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematology (Am Soc Hematol Educ Program). 2008;151-158.
10. Shanmugam NK, Ellenbogen S, Trebicka E, et al. Tumor necrosis factor a inhibits expression of the iron regulating hormone hepcidin in murine models of innate colitis. PLoS ONE. 2012;7(5):e38136.
11. Vecchi C, Montosi G, Zhang K, et al. ER stress controls iron metabolism through induction of hepcidin. Science. 2009;325(5942):877-880.
12. Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721-1741.
13. Pietrangelo A, Dierssen U, Valli L, et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology. 2007;132(1):294-300. (Pubitemid 46108739)
14. Sakamori R, Takehara T, Tatsumi T, et al. STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo. J Gastroenterol. 2010;45(2):244-248.
15. Tron K, Samoylenko A, Musikowski G, et al. Regulation of rat heme oxygenase-1 expression by interleukin-6 via the Jak/STAT pathway in hepatocytes. J Hepatol. 2006;45(1):72-80. (Pubitemid 43850615)
16. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108(9):3204-3209.
17. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal. 2004;16(3):291-299. (Pubitemid 37542404)
18. Steinbicker AU, Sachidanandan C, Vonner AJ, et al. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood. 2011;117(18):4915-4923.
19. Seki T, Yun J, Oh SP. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res. 2003;93(7):682-689. (Pubitemid 37222165)
20. Otu HH, Naxerova K, Ho K, et al. Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns. J Biol Chem. 2007;282(15):11197-11204. (Pubitemid 47100753)
21. Steinbicker AU, Bartnikas TB, Lohmeyer LK, et al. Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood. 2011;118(15):4224-4230.
22. Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38(5):531-539.
23. Theurl I, Schroll A, Sonnweber T, et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood. 2011;118(18):4977-4984.
24. Yu PB, Hong CC, Sachidanandan C, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2008;4(1):33-41. (Pubitemid 350273653)
25. Dudas M, Sridurongrit S, Nagy A, Okazaki K, Kaartinen V. Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech Dev. 2004;121(2):173-182. (Pubitemid 38368822)
26. Mishina Y, Hanks MC, Miura S, Tallquist MD, Behringer RR. Generation of Bmpr/Alk3 conditional knockout mice. Genesis. 2002;32(2):69-72. (Pubitemid 34211699)
27. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007;109(1):353-358. (Pubitemid 46053077)
28. Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med. 2012;366(4):348-359.
29. Rodriguez R, Jung CL, Gabayan V, et al. Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect Immun. 2014;82(2):745-752.
30. Theurl I, Schroll A, Nairz M, et al. Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo. Haematologica. 2011;96(12):1761-1769.
31. Wang RH, Li C, Xu X, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2005;2(6):399-409.
32. Verga Falzacappa MV, Casanovas G, Hentze MW, Muckenthaler MU. A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells. J Mol Med (Berl). 2008;86(5):531-540.
33. Rizzardini M, Zappone M, Villa P, et al. Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: role of interleukin 1beta. Hepatology. 1998;27(3):703-710. (Pubitemid 28103546)
34. Tron K, Novosyadlyy R, Dudas J, Samoylenko A, Kietzmann T, Ramadori G. Upregulation of heme oxygenase-1 gene by turpentine oil-induced localized inflammation: involvement of interleukin-6. Lab Invest. 2005;85(3):376-387. (Pubitemid 40333154)
35. Prince OD, Langdon JM, Layman AJ, et al. Late stage erythroid precursor production is impaired in mice with chronic inflammation. Haematologica. 2012;97(11):1648-1656.
36. Cunha SI, Pietras K. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood. 2011;117(26):6999-7006.
37. Kamiya N, Kaartinen VM, Mishina Y. Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1. Biochem Biophys Res Commun. 2011;414(2):326-330.